Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2B 〉Nang Kuang Pharmaceutical Co., Ltd.

Nang Kuang Pharmaceutical Co., Ltd.

Chat Now My Favorites
Nang Kuang, founded in 1963, is a leading parenteral pharmaceutical company in Taiwan. The facility has passed US FDA and Japan PMDA inspections. Our major products including anticancer injections (isolator system),  large volume parenterals ( LVP; PP-soft bag), aseptic parenterals (Ampoule、Vial), lyophilized injection, aseptic Pre-filled syringe、Pre-mixed IV infusion bags and also solid products. Accredited with superior product quality and innovative technology. Nang Kuang has become the top injectable manufacturer in Taiwan. With annual sales approximately 1,800 million NT dollars (approx. US $50 million) and an existing workforce of close to 570 employees, NangKuang has gone to the public market (IPO) in 2009 as well.
 
 Nang Kuang has been certified by the Taiwan Bureau of Health with respect to cGMP、PIC/S GMP(whole factory) compliance and was also granted ISO14001、TIPS(Taiwan Intellectual Property Scheme) certification along with many export product licenses(we were the  first Pharma firm to export injectable product to Japan market successfully since 17 years ago). Our company has developed a global business strategy for exploring market opportunities in Japan, China, and ASEAN countries. Co-marketing and development products with many pharmaceutical companies in Europe and United States have also been established.

R & D:
  • Product Development Complies with US FDA QbD
  • Product Development of Paragraph IV & 505b2 Submissions
  • Development of Sustained Release Injectable Products
Regulation:
  • Well Experienced with ANDAs Submissions
  • Experienced in Taiwan Pre IND meeting, IND and NDA Submissions
  • PC Chen, R&D Director

    PC Chen, R&D Director

    Specialised in PIV Filing in US & Sustained Controlled Parenteral Development
    PhD Degree in University of Michigan
  • Alan Chen, Global BD Director

    Alan Chen, Global BD Director

    Vice Chair of Global Affair Committee in TPMDA
    Handling Overseas Markets & Strategic Development for Asia
  • Yu Pei Wang, General Manager

    Yu Pei Wang, General Manager

    Chairman of Taiwan Pharma Manufacturer & Development Association
    Specialized in Parenteral Development and GMP
    Bachelor Degree in Pharma from Taipei Medical University
  • Li Shien Chen, CEO

    Li Shien Chen, CEO

    General Manager of NangKuang Pharma
    Leading the Strategic Development for Japan Market
    EMBA Degree in NCKU
Nang Kuang, founded in 1963, is a leading parenteral pharmaceutical company in Taiwan. The facility has passed US FDA and Japan PMDA inspections. Our major products including anticancer injections (isolator system),  large volume parenterals ( LVP; PP-soft bag), aseptic parenterals (Ampoule、Vial), lyophilized injection, aseptic Pre-filled syringe、Pre-mixed IV infusion bags and also solid products. Accredited with superior product quality and innovative technology. Nang Kuang has become the top injectable manufacturer in Taiwan. With annual sales approximately 1,800 million NT dollars (approx. US $50 million) and an existing workforce of close to 570 employees, NangKuang has gone to the public market (IPO) in 2009 as well.
 
 Nang Kuang has been certified by the Taiwan Bureau of Health with respect to cGMP、PIC/S GMP(whole factory) compliance and was also granted ISO14001、TIPS(Taiwan Intellectual Property Scheme) certification along with many export product licenses(we were the  first Pharma firm to export injectable product to Japan market successfully since 17 years ago). Our company has developed a global business strategy for exploring market opportunities in Japan, China, and ASEAN countries. Co-marketing and development products with many pharmaceutical companies in Europe and United States have also been established.

R & D:
  • Product Development Complies with US FDA QbD
  • Product Development of Paragraph IV & 505b2 Submissions
  • Development of Sustained Release Injectable Products
Regulation:
  • Well Experienced with ANDAs Submissions
  • Experienced in Taiwan Pre IND meeting, IND and NDA Submissions